Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Lackner, H; Sovinz, P; Benesch, M; Schwinger, W; Dornbusch, HJ; Moser, A; Triebl-Roth, K; Urban, C.
Immunosuppressive treatment in alopecia universalis. Prednisolone, cyclosporine A, and tacrolimus in a 4 year old boy
MONATSSCHR KINDERHEILK. 2007; 155: S54-S57.
Doi: 10.1007/s00112-005-1245-8
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Lackner Herwig
- Co-Autor*innen der Med Uni Graz
- Benesch Martin
- Dornbusch Hans Jürgen
- Ritter-Sovinz Petra
- Schwinger Wolfgang
- Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Alopecia universalis is characterized by total loss of body hair and can occur at any age, causing significant psychological morbidity in most cases. Though there is evidence to suggest that alopecia universalis is an autoimmune disease, the cause of the disease is still not known with certainty. Spontaneous recovery is unusual (<10%), and the long-term prognosis in cases not responding to therapy is poor, despite the variety of therapies available. Experience of immunosuppressive treatment in children with alopecia universalis is limited. We report on a 4-year-old boy, who was successfully treated for refractory alopecia universalis with prednisolone and cyclosporine A by mouth combined with topical application of tacrolimus. Our case report shows that systemic immunosuppression may be a promising treatment option for some children with alopecia universalis who are badly distressed by their condition. However, potential treatment-related risks have to be weighed against the psychosocial stress experienced by these patients and their families.
- Find related publications in this database (Keywords)
- Alopecia universalis
- systemic immunosuppressive
- therapy children